inrebic | Myelofibrosis Treatment - INREBIC® (fedratinib)

Keyword	CPC	PCC	Volume	Score	Length of keyword
inrebic	1.19	0.2	9615	48	7

Keyword	CPC	PCC	Volume	Score
inrebic	1.26	0.9	7176	37
inrebic 100 mg	1.62	0.1	5474	92
inrebic package insert	0.76	0.6	1667	48
inrebic ema	0.3	0.6	872	62
inrebic chpl	0.2	0.9	1876	38
inrebic vs jakafi	0.79	0.2	4133	88
inrebic fedratinib	0.56	0.1	4673	89
inrebic pi	0.52	0.7	9056	29
inrebic.bms-staging.com	1.99	0.3	5495	28
inrebic uspi	0.52	0.6	18	74
inrebic cost	0.37	0.8	7619	39
inrebic smpc	1.01	1	4588	92
inrebic approval	0.08	0.6	7835	61
inrebic bms	0.64	1	6533	9
inrebic rcp	1.49	0.5	477	18

Search Results related to inrebic on Search Engine

Myelofibrosis Treatment - INREBIC® (fedratinib)
inrebic.com

https://www.inrebic.com/

WEBINREBIC® (fedratinib) is a myelofibrosis treatment option for intermediate-2 or high-risk myelofibrosis (MF). Please see Indication and Important Safety Information including Boxed WARNING.

DA: 89 PA: 77 MOZ Rank: 29 Up or Down: Up

Inrebic: Uses, Dosage, Side Effects, Warnings - Drugs.com
drugs.com

https://www.drugs.com/inrebic.html

WEBFeb 22, 2024 · Inrebic (fedratinib) capsules are used for myelofibrosis (MF) in adults to reduce the symptoms of MF, including night sweats, itching, stomach pain, feeling full when eating, pain under the ribs on the left-hand side, and bone or muscle pain. Inrebic also helps reduce the spleen volume.

DA: 85 PA: 85 MOZ Rank: 39 Up or Down: Up

FDA approves fedratinib for myelofibrosis | FDA
fda.gov

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fedratinib-myelofibrosis

WEBFDA approves fedratinib for myelofibrosis. On August 16, 2019, the Food and Drug Administration approved fedratinib (INREBIC, Impact Biomedicines, Inc.) for adults with intermediate-2 or...

DA: 51 PA: 22 MOZ Rank: 19 Up or Down: Up

Fedratinib - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Fedratinib

WEBFedratinib, sold under the brand name Inrebic, is an anti-cancer medication used to treat myeloproliferative diseases including myelofibrosis. It is used in the form of fedratinib hydrochloride capsules that are taken by mouth.

DA: 21 PA: 56 MOZ Rank: 40 Up or Down: Up

Inrebic Oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
webmd.com

https://www.webmd.com/drugs/2/drug-177752/inrebic-oral/details

WEBInrebic 100 Mg Capsule Antineoplastic - Janus Kinase (JAK) Inhibitors - Uses, Side Effects, and More. Generic Name (S): fedratinib. Uses. Precautions. Uses. This medication is used to treat a...

DA: 50 PA: 18 MOZ Rank: 67 Up or Down: Up

INREBIC® (fedratinib) | For Healthcare Professionals
inrebicpro.com

https://www.inrebicpro.com/

WEBINREBIC ® (fedratinib) is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF). Information for Vermont prescribers of prescription drugs.

DA: 94 PA: 23 MOZ Rank: 10 Up or Down: Up

FDA approves treatment for patients with rare bone marrow disorder
fda.gov

https://www.fda.gov/news-events/press-announcements/fda-approves-treatment-patients-rare-bone-marrow-disorder

WEBToday, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis. “Prior to today, there was one FDA-approved drug...

DA: 100 PA: 36 MOZ Rank: 74 Up or Down: Up

Inrebic (Fedratinib Capsules): Side Effects, Uses, Dosage ... - RxList
rxlist.com

https://www.rxlist.com/inrebic-drug.htm

WEBAug 28, 2023 · What is INREBIC? INREBIC is a prescription medicine used to treat adults with certain types of myelofibrosis (MF). It is not known if INREBIC is safe and effective in children. Before taking INREBIC, tell your healthcare provider about all your medical conditions, including if you: have low red blood cell or platelet counts

DA: 58 PA: 73 MOZ Rank: 100 Up or Down: Up

DailyMed - INREBIC- fedratinib hydrochloride capsule
nih.gov

https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0f55a2a-4e0c-4cba-8571-03e1424486d7

WEB1 INDICATIONS AND USAGE. INREBIC® is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF) ... 2 DOSAGE AND ADMINISTRATION.

DA: 36 PA: 82 MOZ Rank: 79 Up or Down: Up

Fedratinib, a newly approved treatment for patients with
nature.com

https://www.nature.com/articles/s41375-020-0954-2

WEBJul 9, 2020 · Fedratinib is a selective oral JAK2 inhibitor recently approved in the United States for treatment of adult patients with intermediate-2 or high-risk MF.

DA: 41 PA: 41 MOZ Rank: 25 Up or Down: Up